SCHEMBL24508743

SCHEMBL24508743

CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](CO)CC1

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29709746 1.00 IRAK4 (0.84) IRAK4
SCHEMBL21949093 0.92 IRAK4 (0.89) IRAK4
SCHEMBL16873647 0.91 IRAK4 (1.00) IRAK4
SCHEMBL21949048 0.91 IRAK4 (1.00) IRAK4
SCHEMBL25221721 0.91 IRAK4 (0.85) IRAK4
SCHEMBL30459459 0.91 IRAK4 (0.85) IRAK4
SCHEMBL16873642 0.91 IRAK4 (1.00) IRAK4
SCHEMBL21948689 0.91 IRAK4 (0.88) IRAK4
SCHEMBL24607392 0.91 IRAK4 (0.69) IRAK4
Cyclopropane SCHEMBL16878892 0.91 IRAK4 (0.84) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
WO-2022125790-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 — — WO disclosed
Send feedback